SARSVAX: DNA-based vaccine to prevent COVID-19

Michael McConnell

  • PROJECT LEADER

    Michael McConnell

  • HOST ORGANIZATION,
    COUNTRY

    Instituto de Salud Carlos III, Madrid, Spain

  • DESCRIPTION

    There are currently no vaccines available for the prevention of infections caused by the SARS-CoV-2 coronavirus. In this project, a DNA-based vaccine will be designed using technology previously developed at the National Centre for Microbiology of the Instituto de Salud Carlos III.

    Prophylactic vaccination can provide protection from infection on a population scale, thus removing the need to implement social distancing measures in protected populations. The societal impact of an effective vaccine for COVID-19 would therefore be very high on both health and economic levels.

  • MORE INFORMATION

    https://impulse.caixaresearch.org/en-US/web/guest/projects/-/caixaresearch/project/290373